Oscar Health, Inc. (NYSE:OSCR) CFO Sells $511,066.42 in Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 29,957 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $511,066.42. Following the sale, the chief financial officer now owns 853,875 shares of the company’s stock, valued at approximately $14,567,107.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, September 3rd, Richard Scott Blackley sold 68,978 shares of Oscar Health stock. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22.

Oscar Health Trading Up 18.7 %

Shares of Oscar Health stock opened at $20.67 on Thursday. The stock has a fifty day simple moving average of $17.10 and a 200 day simple moving average of $17.27. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12-month low of $4.72 and a 12-month high of $23.44. The company has a market capitalization of $4.90 billion, a P/E ratio of -51.68, a price-to-earnings-growth ratio of 33.66 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the previous year, the firm earned ($0.07) earnings per share. The business’s revenue was up 44.6% on a year-over-year basis. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. American International Group Inc. boosted its position in Oscar Health by 1.3% in the first quarter. American International Group Inc. now owns 79,411 shares of the company’s stock worth $1,181,000 after purchasing an additional 1,009 shares during the last quarter. Summit Trail Advisors LLC boosted its position in Oscar Health by 5.4% in the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock worth $329,000 after purchasing an additional 1,065 shares during the last quarter. Arizona State Retirement System boosted its position in Oscar Health by 3.7% in the second quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock worth $602,000 after purchasing an additional 1,351 shares during the last quarter. Amalgamated Bank boosted its position in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. Finally, New York State Common Retirement Fund boosted its position in Oscar Health by 3.8% in the fourth quarter. New York State Common Retirement Fund now owns 64,856 shares of the company’s stock worth $593,000 after purchasing an additional 2,394 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on OSCR. Bank of America restated a “neutral” rating and set a $21.00 price objective (down previously from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Baird R W upgraded Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Wells Fargo & Company upped their price target on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Robert W. Baird assumed coverage on Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 price target for the company. Finally, Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a report on Tuesday. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $24.17.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.